Clinical Trials Browser

Phase 1/2 × Carcinoma, Hepatocellular × penpulimab × Clear all

NCT07075419 2025-07-20

JDB153 Combined With Penpulimab for Hepatocellular Carcinoma After Standard Treatment Failure

Phase 1/2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular